| Assessment Status |
Rapid Review Complete |
| HTA ID |
- |
| Drug |
Diclofenac |
| Brand |
Itami® |
| Indication |
For the local symptomatic and short-term treatment (max. 7 days) of pain in acute strains, sprains or bruises of the extremities following blunt trauma e.g. sports injuries in adolescents aged from 16 years and adults |
| Rapid review commissioned |
31/12/2018 |
| Rapid review completed |
17/01/2019 |
| Rapid review outcome |
A full HTA is not recommended. The NCPE recommends that diclofenac 140mg Medicated Plaster (Itami®) not be considered for reimbursement. This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013. |
